‘Pay-for-Delay’ Drug Case Moves Forward

Thursday, July 26, 2012 - 01:30 in Mathematics & Economics

The European Commission said smaller companies agreed to keep generics temporarily off the market in exchange for money from makers like Lundbeck.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net